New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 02  •  04:00PM ET
6.75
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-15.97 Insider Own66.66% Shs Outstand9.02M Perf Week0.64%
Market Cap60.91M Forward P/E- EPS next Y- Insider Trans-0.55% Shs Float3.01M Perf Month0.49%
Enterprise Value- PEG- EPS next Q- Inst Own6.99% Short Float0.56% Perf Quarter-1.70%
Income-134.80M P/S0.07 EPS this Y- Inst Trans- Short Ratio2.70 Perf Half Y2.32%
Sales890.44M P/B- EPS next Y- ROA-11.55% Short Interest0.02M Perf YTD-8.99%
Book/sh-151.72 P/C- EPS next 5Y- ROE- 52W High7.66 -11.84% Perf Year29.37%
Cash/sh- P/FCF- EPS past 3/5Y46.84% -7.17% ROIC- 52W Low3.79 78.18% Perf 3Y-92.66%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-14.77% 27.26% Gross Margin- Volatility1.63% 2.12% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM87.09% Oper. Margin-3.26% ATR (14)0.15 Perf 10Y-
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM-13.83% Profit Margin-15.14% RSI (14)53.05 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio0.70 EPS Q/Q69.74% SMA200.42% Beta0.60 Target Price7.00
Payout- Debt/Eq- Sales Q/Q-7.48% SMA500.74% Rel Volume0.00 Prev Close6.75
Employees986 LT Debt/Eq- EarningsAug 07 BMO SMA2000.13% Avg Volume6.29K Price6.75
IPOJun 24, 2021 Option/ShortNo / No EPS/Sales Surpr.-1427.27% -4.44% Trades Volume180 Change0.00%
Date Action Analyst Rating Change Price Target Change
Oct-11-22Downgrade JP Morgan Neutral → Underweight
Mar-29-22Downgrade JP Morgan Overweight → Neutral
Mar-04-22Downgrade RBC Capital Mkts Outperform → Sector Perform $9 → $3
Mar-02-22Downgrade BofA Securities Buy → Underperform
Jan-10-22Resumed Citigroup Neutral $5 → $3.50
Dec-16-21Downgrade Morgan Stanley Equal-Weight → Underweight $5 → $4
Dec-14-21Initiated Goldman Neutral $5
Dec-10-21Upgrade JP Morgan Neutral → Overweight $6
Nov-12-21Downgrade Morgan Stanley Overweight → Equal-Weight $13 → $5
Nov-02-21Downgrade Cowen Outperform → Market Perform $14 → $9
Oct-02-25 09:16AM
Aug-07-25 06:56AM
06:45AM
Jul-17-25 08:00AM
Jul-16-25 06:45AM
11:28AM Loading…
Jun-02-25 11:28AM
May-09-25 03:13AM
May-08-25 06:45AM
Apr-23-25 08:00AM
Mar-20-25 01:14PM
06:45AM
Feb-26-25 08:00AM
Dec-23-24 05:53PM
Nov-07-24 06:45AM
Oct-30-24 06:45AM
08:00AM Loading…
Oct-17-24 08:00AM
Sep-19-24 12:00PM
Aug-07-24 06:45AM
Jul-18-24 08:00AM
Jun-24-24 06:45AM
Jun-18-24 04:30PM
Jun-06-24 07:47AM
May-11-24 08:41AM
May-08-24 06:45AM
Apr-18-24 08:00AM
Apr-09-24 05:29PM
Mar-06-24 08:01AM
06:45AM
Feb-20-24 08:00AM
Jan-18-24 05:38AM
04:05PM Loading…
Jan-17-24 04:05PM
Jan-02-24 04:30PM
Dec-29-23 06:45AM
Nov-09-23 01:23PM
Nov-07-23 09:33AM
07:26AM
06:45AM
Oct-13-23 08:00AM
Sep-19-23 06:45AM
Aug-09-23 08:53PM
08:05AM
06:54AM
06:45AM
Aug-07-23 06:45AM
Aug-02-23 08:15AM
Jul-17-23 08:00AM
Jul-13-23 06:20AM
Jul-12-23 03:29PM
Jul-03-23 12:24PM
08:41AM
Jun-30-23 06:45AM
Jun-09-23 07:59AM
May-09-23 08:05AM
06:57AM
06:45AM
May-03-23 05:00PM
Apr-28-23 08:00AM
Apr-25-23 04:05PM
Mar-29-23 07:20AM
Mar-02-23 09:19PM
05:38AM
02:30AM
Mar-01-23 08:05AM
06:45AM
Feb-22-23 08:05PM
Feb-14-23 07:08AM
Feb-10-23 01:50PM
08:00AM
Feb-01-23 03:15PM
Jan-18-23 05:51AM
Jan-10-23 07:00AM
Jan-04-23 12:00PM
Dec-21-22 08:46AM
Dec-12-22 04:30PM
Nov-10-22 04:30PM
Nov-09-22 03:37PM
02:42PM
08:05AM
Nov-07-22 08:05AM
Oct-19-22 07:30AM
Oct-18-22 07:30AM
Oct-11-22 03:16PM
07:00AM
Sep-13-22 02:22PM
Aug-10-22 04:00PM
07:55AM
06:45AM
Aug-08-22 05:45PM
Aug-05-22 03:06PM
Aug-04-22 06:15PM
Jul-26-22 08:00AM
Jul-25-22 05:45PM
Jul-22-22 11:25AM
Jun-22-22 11:18AM
May-17-22 04:05PM
May-08-22 08:21AM
May-04-22 04:01PM
06:45AM
Apr-19-22 08:30AM
Apr-14-22 05:26PM
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The firm offers individual, family, and Medicare advantage health plans. It operates through the NeueCare and NeueSolutions segments. The NeueCare segment delivers healthcare to all populations across the ACA marketplace, Medicare, and Medicaid through owned and affiliated clinics. The NeueSolutions segment provides a suite of technology, services, and clinical care solutions. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Doral, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Makhzoumi MohamadDirectorOct 02 '25Option Exercise0.013,948,67539,4872,385,055Oct 06 05:54 PM
SANDELL SCOTT DDirectorOct 02 '25Option Exercise0.011,116,76511,1682,385,055Oct 06 05:54 PM
SANDELL SCOTT DDirectorOct 02 '25Sale6.754,19528,316488,702Oct 06 05:54 PM
Florence Anthony A. Jr.DirectorOct 02 '25Option Exercise0.011,116,76511,1682,385,055Oct 06 05:53 PM
Florence Anthony A. Jr.DirectorOct 02 '25Sale6.754,19528,316488,702Oct 06 05:53 PM
Walker Paul EdwardDirectorOct 02 '25Option Exercise0.01682,4686,8252,385,055Oct 06 05:53 PM
Walker Paul EdwardDirectorOct 02 '25Sale6.753,91526,426488,702Oct 06 05:53 PM
Chang CarmenDirectorOct 02 '25Option Exercise0.01682,4686,8252,385,055Oct 06 05:52 PM
Chang CarmenDirectorOct 02 '25Sale6.753,91526,426488,702Oct 06 05:52 PM
Behbahani AliDirectorOct 02 '25Option Exercise0.01682,4686,8252,385,055Oct 06 05:52 PM
Behbahani AliDirectorOct 02 '25Sale6.753,91526,426488,702Oct 06 05:52 PM
Yang RickDirectorOct 02 '25Option Exercise0.01310,2133,1022,385,055Oct 06 05:51 PM
Yang RickDirectorOct 02 '25Sale6.753,63524,536488,702Oct 06 05:51 PM
Mathers Edward TDirectorOct 02 '25Option Exercise0.01310,2133,1022,385,055Oct 06 05:50 PM
Mathers Edward TDirectorOct 02 '25Sale6.753,63524,536488,702Oct 06 05:50 PM
BASKETT FORESTDirectorOct 02 '25Option Exercise0.01992,6809,9271,961,234Oct 06 05:50 PM
BASKETT FORESTDirectorOct 02 '25Sale6.758405,670488,702Oct 06 05:50 PM
NEA 18 Venture Growth Equity, DirectorOct 02 '25Option Exercise0.01124,0851,2412,385,055Oct 06 05:49 PM
NEA 18 Venture Growth Equity, DirectorOct 02 '25Sale6.753,35522,6461,654,334Oct 06 05:49 PM
New Enterprise Associates 17, DirectorOct 02 '25Option Exercise0.01186,1281,861674,830Oct 06 05:49 PM
New Enterprise Associates 17, DirectorOct 02 '25Sale6.752801,890488,702Oct 06 05:49 PM
New Enterprise Associates 16, DirectorOct 02 '25Option Exercise0.01372,2553,7231,160,234Oct 06 05:48 PM
New Enterprise Associates 16, DirectorOct 02 '25Sale6.752801,890787,979Oct 06 05:48 PM
NEA 15 GP, LLCDirectorOct 02 '25Option Exercise0.01434,2974,3431,961,234Oct 06 05:48 PM
NEA 15 GP, LLCDirectorOct 02 '25Sale6.752801,8901,526,937Oct 06 05:48 PM
New Enterprise Associates 15, DirectorOct 02 '25Option Exercise0.01434,2974,3431,961,234Oct 06 05:48 PM
New Enterprise Associates 15, DirectorOct 02 '25Sale6.752801,8901,526,937Oct 06 05:48 PM
IMMELT JEFFREY RDirectorMay 13 '25Option Exercise0.0010,500023,919May 15 06:45 PM
ADKINS KEDRICK D JRDirectorMay 13 '25Option Exercise0.0010,500016,443May 15 06:39 PM
Kadre ManuelDirectorMay 13 '25Option Exercise0.0010,500029,820May 15 06:34 PM
Gooden Linda RDirectorMay 13 '25Option Exercise0.0010,500016,443May 15 06:27 PM
Sheehy Robert JDirectorMay 13 '25Option Exercise0.0010,500015,255May 15 06:20 PM
Makhzoumi MohamadDirectorMay 13 '25Option Exercise0.0010,500016,443May 15 06:18 PM
Kraus StephenDirectorMay 13 '25Option Exercise0.0010,500016,444May 15 06:15 PM
Manders Matthew GDirectorMay 13 '25Option Exercise0.0010,500016,741May 15 06:15 PM
Slavitt Andrew MDirectorMay 13 '25Option Exercise0.0010,500018,529May 15 06:07 PM
Scherman Jeffrey JChief Accounting OfficerMay 12 '25Sale6.7611275712,463May 14 05:23 PM
Matushak JayChief Financial OfficerMay 12 '25Sale6.764723,19140,556May 14 05:21 PM
Scherman Jeffrey JChief Accounting OfficerMar 13 '25Sale6.741,0206,87512,587Mar 17 08:40 PM
Scherman Jeffrey JChief Accounting OfficerMar 14 '25Sale6.133532,16412,234Mar 17 08:40 PM
Craig Jeffery MichaelGC & Corporate SecretaryMar 13 '25Sale6.742,59517,49021,003Mar 17 08:39 PM
Craig Jeffery MichaelGC & Corporate SecretaryMar 14 '25Sale6.138995,51120,104Mar 17 08:39 PM
Orozco TomasEVP, Consumer CareMar 13 '25Sale6.743,54023,86030,551Mar 17 08:38 PM
Orozco TomasEVP, Consumer CareMar 14 '25Sale6.131,2267,51529,325Mar 17 08:38 PM
Matushak JayChief Financial OfficerMar 13 '25Sale6.744,44829,98041,592Mar 17 08:37 PM
Matushak JayChief Financial OfficerMar 14 '25Sale6.131,5429,45240,050Mar 17 08:37 PM
Mikan George Lawrence IIICEO & PresidentMar 13 '25Sale6.7435,896241,939261,894Mar 17 08:36 PM
Mikan George Lawrence IIICEO & PresidentMar 14 '25Sale6.1312,44076,257249,454Mar 17 08:36 PM
Scherman Jeffrey JChief Accounting OfficerMar 11 '25Sale6.854272,9258,482Mar 13 09:55 PM
Scherman Jeffrey JChief Accounting OfficerMar 12 '25Sale6.933752,59913,607Mar 13 09:55 PM
Craig Jeffery MichaelGC & Corporate SecretaryMar 12 '25Sale6.939536,60423,598Mar 13 09:52 PM
Craig Jeffery MichaelGC & Corporate SecretaryMar 11 '25Sale6.851951,33610,551Mar 13 09:52 PM
Orozco TomasEVP, Consumer CareMar 12 '25Sale6.931,3009,00934,091Mar 13 09:49 PM
Orozco TomasEVP, Consumer CareMar 11 '25Sale6.856174,22611,391Mar 13 09:49 PM
Matushak JayChief Financial OfficerMar 12 '25Sale6.931,63311,31746,040Mar 13 09:47 PM
Matushak JayChief Financial OfficerMar 11 '25Sale6.858145,57623,673Mar 13 09:47 PM
Mikan George Lawrence IIICEO & PresidentMar 12 '25Sale6.9313,18091,337297,790Mar 13 09:45 PM
Mikan George Lawrence IIICEO & PresidentMar 11 '25Sale6.853,74725,667180,970Mar 13 09:45 PM
Scherman Jeffrey JChief Accounting OfficerMar 07 '25Sale7.196204,4587,813Mar 11 09:51 PM
Scherman Jeffrey JChief Accounting OfficerMar 10 '25Sale7.061841,2998,909Mar 11 09:51 PM
Craig Jeffery MichaelGC & Corporate SecretaryMar 07 '25Sale7.191,2408,91610,167Mar 11 09:51 PM
Craig Jeffery MichaelGC & Corporate SecretaryMar 10 '25Sale7.0621410,746Mar 11 09:51 PM
Orozco TomasEVP, Consumer CareMar 07 '25Sale7.196204,4589,701Mar 11 09:50 PM
Orozco TomasEVP, Consumer CareMar 10 '25Sale7.062014112,008Mar 11 09:50 PM
Matushak JayChief Financial OfficerMar 07 '25Sale7.191,86013,37322,227Mar 11 09:50 PM
Matushak JayChief Financial OfficerMar 10 '25Sale7.061841,29924,487Mar 11 09:50 PM
Mikan George Lawrence IIICEO & PresidentMar 07 '25Sale7.1926,660191,685178,756Mar 11 09:49 PM
Mikan George Lawrence IIICEO & PresidentMar 10 '25Sale7.061,60411,324184,717Mar 11 09:49 PM
Scherman Jeffrey JChief Accounting OfficerJan 06 '25Sale7.331,36810,0275,942Jan 08 08:58 PM
Craig Jeffery MichaelGC & Corporate SecretaryJan 06 '25Sale7.332,48618,2227,558Jan 08 08:57 PM
Matushak JayChief Financial OfficerJan 06 '25Sale7.334,97036,43017,747Jan 08 08:55 PM
Orozco TomasEVP, Consumer CareJan 06 '25Sale7.331,2339,0387,830Jan 08 08:54 PM
Mikan George Lawrence IIICEO & PresidentJan 06 '25Sale7.3331,798233,079146,539Jan 08 08:53 PM
Mikan George Lawrence IIICEO & PresidentDec 17 '24Sale4.1816,80370,23783,029Dec 18 09:15 PM
Last Close
Oct 06  •  04:00PM ET
1.08
Dollar change
+0.13
Percentage change
13.10
%
MRKR Marker Therapeutics Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.37 Insider Own28.91% Shs Outstand11.31M Perf Week16.59%
Market Cap13.97M Forward P/E- EPS next Y-1.74 Insider Trans0.00% Shs Float9.20M Perf Month20.43%
Enterprise Value2.16M PEG- EPS next Q-0.36 Inst Own9.82% Short Float9.40% Perf Quarter-32.50%
Income-14.61M P/S2.59 EPS this Y-26.05% Inst Trans-7.47% Short Ratio0.43 Perf Half Y8.00%
Sales5.39M P/B1.16 EPS next Y-15.67% ROA-110.48% Short Interest0.86M Perf YTD-65.27%
Book/sh0.93 P/C1.18 EPS next 5Y7.89% ROE-144.68% 52W High5.95 -81.85% Perf Year-58.30%
Cash/sh0.91 P/FCF- EPS past 3/5Y39.79% 23.96% ROIC-139.25% 52W Low0.81 33.35% Perf 3Y-71.08%
Dividend Est.- EV/EBITDA- Sales past 3/5Y74.44% 98.63% Gross Margin- Volatility7.61% 7.28% Perf 5Y-92.94%
Dividend TTM- EV/Sales0.40 EPS Y/Y TTM-17.92% Oper. Margin-272.41% ATR (14)0.08 Perf 10Y-98.47%
Dividend Ex-Date- Quick Ratio3.45 Sales Y/Y TTM44.55% Profit Margin-271.11% RSI (14)58.88 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio3.45 EPS Q/Q-17.00% SMA2015.76% Beta1.45 Target Price6.00
Payout- Debt/Eq0.00 Sales Q/Q-26.35% SMA500.84% Rel Volume0.52 Prev Close0.95
Employees5 LT Debt/Eq0.00 EarningsAug 18 SMA200-30.07% Avg Volume2.00M Price1.08
IPOJan 05, 1998 Option/ShortNo / Yes EPS/Sales Surpr.17.74% 104.48% Trades Volume1,050,753 Change13.10%
Date Action Analyst Rating Change Price Target Change
Mar-05-25Initiated Canaccord Genuity Buy $8
Mar-25-21Initiated Piper Sandler Overweight $6
Mar-19-21Initiated Cantor Fitzgerald Overweight $6
May-12-20Downgrade Piper Sandler Overweight → Neutral $5 → $2.50
May-30-19Initiated ROTH Capital Buy
Mar-01-19Initiated Janney Buy
Dec-03-18Upgrade Piper Jaffray Neutral → Overweight
Oct-06-25 07:30AM
Aug-28-25 08:00AM
Aug-27-25 12:02PM
Aug-26-25 10:30AM
07:00AM
08:00AM Loading…
Jul-30-25 08:00AM
Jul-17-25 10:30AM
Jun-17-25 08:00AM
May-20-25 08:00AM
May-19-25 08:00AM
Apr-01-25 08:00AM
Mar-31-25 08:45AM
Feb-25-25 07:00AM
Dec-19-24 08:06AM
08:05AM
07:00AM Loading…
Dec-17-24 07:00AM
Dec-10-24 08:30AM
08:30AM
Nov-26-24 11:00AM
Nov-14-24 04:30PM
Oct-22-24 08:20AM
Sep-26-24 02:33PM
Aug-28-24 08:00AM
Aug-14-24 04:30PM
Aug-12-24 07:00AM
Jun-28-24 11:52AM
May-15-24 11:53PM
04:15PM
Apr-08-24 07:00AM
Mar-25-24 05:45PM
12:30PM Loading…
Mar-22-24 12:30PM
Jan-22-24 07:30AM
Jan-08-24 09:31AM
08:24AM
Dec-21-23 11:00AM
Dec-11-23 07:00AM
Nov-09-23 05:00PM
Sep-11-23 07:00AM
Aug-30-23 08:00AM
Aug-25-23 12:07PM
Aug-17-23 09:03AM
Aug-14-23 04:30PM
Aug-07-23 07:00AM
Jul-26-23 07:00AM
Jul-22-23 08:12AM
Jul-10-23 07:00AM
Jun-26-23 07:00AM
Jun-12-23 07:00AM
May-31-23 06:30AM
May-17-23 06:11AM
May-08-23 07:30AM
May-01-23 07:30AM
Mar-22-23 08:10AM
Dec-13-22 07:23PM
07:00AM
Nov-22-22 07:28AM
07:00AM
Nov-10-22 05:35PM
04:05PM
Sep-13-22 07:00AM
Sep-08-22 07:00AM
Aug-11-22 04:22PM
Aug-04-22 04:37PM
Jun-15-22 07:06AM
May-13-22 07:00AM
May-04-22 10:30AM
Apr-26-22 07:00AM
Mar-17-22 05:45PM
Mar-07-22 04:05PM
Feb-17-22 01:08PM
Feb-16-22 04:30PM
Feb-08-22 04:05PM
Jan-20-22 06:38AM
Jan-19-22 04:49PM
Jan-06-22 08:53AM
Dec-31-21 09:40AM
Dec-09-21 07:00AM
Nov-18-21 04:05PM
Nov-10-21 04:05PM
Oct-08-21 09:24AM
Sep-07-21 04:05PM
Aug-20-21 12:00PM
Aug-19-21 04:05PM
Aug-10-21 04:01PM
Aug-09-21 06:57AM
Jul-28-21 04:05PM
Jul-06-21 07:00AM
Jun-29-21 09:01AM
Jun-16-21 04:05PM
May-20-21 04:06AM
May-12-21 04:05PM
02:45PM
Apr-29-21 04:05PM
Apr-27-21 07:41PM
Apr-08-21 03:23PM
Apr-07-21 08:32AM
Mar-16-21 04:57PM
Mar-15-21 07:00AM
Mar-12-21 08:00AM
Mar-11-21 04:10PM
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ELMS STEVEDirectorDec 23 '24Buy3.2011,08535,472325,370Dec 26 04:01 PM
New Enterprise Associates 16, 10% OwnerDec 23 '24Buy3.20554,2501,773,6001,625,678Dec 23 04:40 PM